Caspase activation and mitochondrial cytochrome c release during hypoxia-mediated apoptosis of adult ventricular myocytes

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 1, 2000, Pages 53-63

  Moissac, Danielle De ^a   Gurevich, Rhonna M ^a   Zheng, Hui ^a   Singal, Pawan K ^a   Kirshenbaum, Lorrie A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adult ventricular myocytes; Apoptosis; Caspases; Cytochrome c; Hypoxia

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CASPASE; CASPASE 3; CYTOCHROME C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; HEART FUNCTION; HEART MUSCLE CELL; HYPOXIA; HYPOXIC CELL; IMMUNOBLOTTING; MALE; MITOCHONDRIAL MEMBRANE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033959317     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1057     Document Type: Article

References (57)

1. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
2. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
3. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apopÍtosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
4. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed JC. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp Cell Res. 219:1995;110-121.
5. Kajstura J, Cheng W, Reiss K, Clark WAR, Sonnenblick EH, Krajewski S et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
6. Black SC, Huang JQ, Rezaiefar P, Radinovic S, Eberhart A, Nicholson DW et al. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol. 30:1998;733-742.
7. Long X, Boluyt MO, Hipolito ML, Lundberg MS, Zheng JS, O'Neill L, Cirielli C, Lakatta EG, Crow MT. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest. 99:1997;2635-2643.
8. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure [see comments]. N Engl J Med. 335:1996;1182-1189.
9. Xue D, Horvitz HR. Inhibition of the CaeÍnorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature. 377:1995;248-251.
10. Hengartner MO, Horvitz HR. Programmed cell death in Caernorhabditis elegans. Curr Opin Genet Dev. 4:1994;581-586.
11. Schwartz LM, Osborne BA. Ced-3/ICE: evolutionarily conserved regulation of cell death. Bioessays. 16:1994;387-389.
12. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 76:1994;665-676.
13. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-. Cell. 75:1993;653-660.
14. Korsmeyer SJ. Regulators of cell death. Trends Genet. 11:1995;101-105.
15. Kumar S. ICE-like proteases in apoptosis. Trends Biochem Sci. 20:1995;198-202.
16. Thornberry NA, Molineaux SM. Interleukin-1 beta converting enzyme: a novel cysteine protease re- quired for IL-1 beta production and implicated in programmed cell death. Protein Sci. 4:1995;3-12.
17. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW et al. Human ICE/CED-3 protease nomenclature [letter]. Cell. 87:1996;171-171.
18. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
19. Pan G, O'Rourke K, Dixit VM. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem. 273:1998;5841-5845.
20. Zamzami N, Hirsch T, Dallaporta B, Petit PX, Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J Bioenerg Biomembr. 29:1997;185-193.
21. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today. 18:1997;44-51.
22. Kluck RM, Martin SJ, Hoffman BM, Zhou JS, Green DR, Newmeyer DD. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16:1997;4639-4649.
23. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 [see comments]. Cell. 90:1997;405-413.
24. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
25. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 22:1997;299-306.
26. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis [see comments]. Nature. 376:1995;37-43.
27. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA. 92:1995;9042-9046.
28. Kirshenbaum LA, MacLellan WR, Mazur W, French BA, Schneider MD. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest. 92:1993;381-387.
29. Kirshenbaum LA, Singal PK. Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation. Lab Invest. 67:1992;796-803.
30. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, Schneider MD. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardiumin vivo. J Clin Invest. 100:1997;2722-2728.
31. Kirshenbaum LA, Singal PK. Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol. 70:1992;1330-1335.
32. Milligan CE, Prevette D, Yaginuma H, Homma S, Cardwell C, Fritz LC, Tomaselli KJ, Oppenheim RW, Schwartz LM. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron. 15:1995;385-393.
33. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, Holtzman DM. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury [see comments]. J Clin Invest. 101:1998;1992-1999.
34. Gottlieb RA, Gruol DL, Zhu JY, Engler RL. Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 97:1996;2391-2398.
35. Kirshenbaum LA, de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 96:1997;1580-1585.
36. Kirshenbaum LA. Adenovirus mediated-gene transfer into cardiomyocytes. Mol Cell Biochem. 172:1997;13-21.
37. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
38. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola-Rosen LA et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol. 140:1998;1485-1495.
39. Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM et al. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med. 187:1998;487-496.
40. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 184:1996;1155-1160.
41. Malhotra R, Brosius FC III. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem. 274:1999;12567-12575.
42. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T et al. Hypoxia induces apopÍtosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
43. Long X, Crow MT, Sollott SJ, O'Neill L, Menees DS, de Lourdes Hipolito M et al. Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes. J Clin Invest. 101:1998;1453-1461.
44. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest. 100:1997;1363-1372.
45. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79:1996;949-956.
46. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor [see comments]. Circulation. 97:1998;276-281.
47. Akiyama K, Gluckman TL, Terhakopian A, Jinadasa PM, Narayan S, Singaswamy S et al. ApopÍtosis in experimental myocardial infarction in situ and in the perfused heart in vitro. Tissue Cell. 29:1997;733-743.
48. Quaini F, Cigola E, Lagrasta C, Saccani G, Quaini E, Rossi C et al. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res. 75:1994;1050-1063.
49. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
50. Kumar S, Harvey NL. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 375:1995;169-173.
51. Macdonald G, Shi L, Velde CV, Lieberman J, Greenberg AH. Mitochondria-dependent and -independent regulation of granzyme B-induced apoptosis [In Process Citation]. J Exp Med. 189:1999;131-144.
52. Pan G, Humke EW, Dixit VM. Activation of caspases triggered by cytochrome c in vitro. FEBS Lett. 426:1998;151-154.
53. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
54. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 144:1999;281-292.
55. Zhuang J, Cohen GM. Release of mitochondrial cytochrome c is upstream of caspase activation in chemical-induced apoptosis in human monocytic tumour cells. Toxicol Lett. 102-3:1998;121-129.
56. Murashita T, Borgers M, Hearse DJ. Developmental changes in tolerance to ischaemia in the rabbit heart: disparity between interpretations of structural, enzymatic and functional indices of injury. J Mol Cell Cardiol. 24:1992;1143-1154.
57. Yano Y, Braimbridge MV, Hearse DJ. Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart. J Thorac Cardiovasc Surg. 94:1987;887-896.